| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36f33186cf137d24cff3848e5b67c5ad |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 |
| filingDate |
2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9156036e5b1492de19f29c10d8462ae6 |
| publicationDate |
2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10047053-B2 |
| titleOfInvention |
Deuterated CFTR potentiators |
| abstract |
This invention relates to compounds of Formula I: n nand pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10479766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10738036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10759721-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022041557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894773-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708331-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018125838-A1 |
| priorityDate |
2011-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |